About
Ophidion is a CNS biopharmaceutical company developing a proprietary non-invasive carrier technology to deliver gene-silencing agents and other therapeutics across the blood-brain barrier to treat neurodegenerative and other central nervous system disorders.
Explore Ophidion's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.